Lobbying disclosures · Lobbying report
AMGN: second_quarter 2026 lobbying report
Issues related to drug pricing and reimbursement for prescription drugs.
Follow AMGN- Became public
- Jun 1, 2026, 4:00 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 11:40 AM EST
Why this is connected
Exact legal-name match: AMGEN INC (https://www.sec.gov/Archives/edgar/data/318154/).
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/070892f7-39e6-47b6-ac68-5b8f4cb5276f/","filing_uuid":"070892f7-39e6-47b6-ac68-5b8f4cb5276f","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/070892f7-39e6-47b6-ac68-5b8f4cb5276f/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Tracy Spicer","dt_posted":"2026-06-01T16:00:35-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"401 9th St. NW","registrant_address_2":"Suite 720","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":72111,"url":"https://lda.gov/api/v1/registrants/72111/","house_registrant_id":35940,"name":"AVENUE SOLUTIONS","description":"Government representation","address_1":"401 9th St. NW","address_2":"Suite 720","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMY TEJRAL","contact_telephone":"+1 202-347-9848","dt_updated":"2026-07-30T13:56:38.410932-04:00"},"client":{"id":73362,"url":"https://lda.gov/api/v1/clients/73362/","client_id":73362,"name":"AMGEN, INC.","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-04-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to drug pricing and reimbursement for prescription drugs.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":149107,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"FUENTES","suffix":null,"suffix_display":null},"covered_position":"LA - Senate Democratic Minority Leader Sen. Chuck Schumer; LA -Senate Democratic Majority Leader Sen. Chuck Schumer; Legislative Aide - Sen. Chuck Schumer; Research Assistant - Senate Finance Committee (Sen. Ron Wyden)","new":true},{"lobbyist":{"id":23462,"prefix":null,"prefix_display":null,"first_name":"TRACY","nickname":null,"middle_name":null,"last_name":"SPICER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in AMGN
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 2, 2026$15K–$50K
Sen. Sheldon Whitehouse (D-RI)
$15K–$50K · Traded Oct 15, 2026 · disclosed Nov 2, 2026 · Spouse
Committee overlap: Finance - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 1, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Sep 22, 2026 · disclosed Oct 1, 2026
- Sep 5, 2026$1K–$15K
- Sep 5, 2026$1K–$15K
- Sep 2, 2026$1K–$15K
Sen. Sheldon Whitehouse (D-RI)
$1K–$15K · Traded Aug 12, 2026 · disclosed Sep 2, 2026 · Spouse
Committee overlap: Finance - Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 12, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Jun 5, 2026 · disclosed Jun 12, 2026
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.